Deferred Versus Upfront Cytoreductive Nephrectomy in MetaStatic Renal Cell Carcinoma: Comparative Survival Analysis in the Immunotherapy Era
dCN may be associated with improved survival outcomes compared to uCN in selected mRCC patients receiving immunotherapy, and careful patient selection for dCN or uCN is essential.
Authors
- Yu‐Zheng Ge (ORCID: https://orcid.org/0000-0003-1615-9473)
- Yiguan Qian (ORCID: https://orcid.org/0000-0002-6715-4536)
- Paerhati Tuerxun
- Kai Zhao (ORCID: https://orcid.org/0000-0003-4805-2689)
- Xiaotian Jiang (ORCID: https://orcid.org/0000-0002-2629-8728)
- Chen Ji (ORCID: https://orcid.org/0000-0003-4919-3299)
- Min Wang (ORCID: https://orcid.org/0000-0002-4067-9068)
- Yang Li (ORCID: https://orcid.org/0000-0002-4277-9214)
- Ning Liu (ORCID: https://orcid.org/0000-0003-0257-1889)
- Rui-Peng Jia (ORCID: https://orcid.org/0000-0003-0444-8534)
- Zhiguo Xiong (ORCID: https://orcid.org/0000-0001-7621-1312)
- Abudukelimu Abudushataer
Institutions
- Associação Brasileira da Batata (BR)
- Yuxian People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-26
- DOI
- https://doi.org/10.3390/cancers17193136
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00